Work

Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.602

Authors: Sherene Loi, Prudence A. Francis, Nicholas Zdenkowski, Val Gebski, Stephen B. Fox, Michelle White, Belinda Emma Kiely, Natasha E. Woodward, Rina Hui, Andrew David Redfern, Raewyn Calvert, Lauren Rennie, Frances M. Boyle, Breast Cancer Trials-Australia and New Zealand

Institutions: Peter MacCallum Cancer Centre, Breast Cancer Trials, The University of Sydney, Monash Health, Mater Health Services, Westmead Hospital, Fiona Stanley Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281648792

Cites:

Cited by: 20

Related to: 10